Struggling Can Also Show on the Inside: Current Knowledge of the Impact of Childhood Maltreatment on Biomarkers in Mood Disorderss
Maj Vinberg,Roger McIntyre,Annamaria Giraldi,Klara Coello
DOI: https://doi.org/10.2147/ndt.s383322
IF: 2.989
2024-03-13
Neuropsychiatric Disease and Treatment
Abstract:Maj Vinberg, 1, 2 Roger S McIntyre, 3, 4 Annamaria Giraldi, 2, 5, &ast Klara Coello 6, &ast 1 Mental Health Centre Northern Zealand, the Early Multimodular Prevention, and Intervention Research Institution (EMPIRI) – Mental Health Services CPH, Copenhagen, Denmark; 2 Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 3 Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada; 4 Institute of Medical Science, University of Toronto, Toronto, ON, Canada; 5 Sexological Clinic, Mental Health Center Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark; 6 Copenhagen Affective Disorder Research Centre (CADIC), Psychiatric Centre Copenhagen, Frederiksberg, Denmark &astThese authors contributed equally to this work Correspondence: Maj Vinberg, Dyrehavevej 48, Hillerød, 3400, Denmark, Tel +453864 3227, Email The link between childhood maltreatment and mood disorders is complex and involves multiple bio-psycho-social factors that affect multiple molecular pathways. The present narrative review aims to clarify the current understanding of the impact of childhood maltreatment on biomarkers in patients with mood disorders and their first-degree relatives. Neurotransmitters, such as serotonin, dopamine, norepinephrine, and hormones (eg the stress hormone cortisol), play a crucial role in regulating mood and emotion. Childhood maltreatment can alter and affect the levels and functioning of these neurotransmitters in the brain; further, childhood maltreatment can lead to structural and connectivity changes in the brain, hence contributing to the development of mood disorders and moderating illness presentation and modifying response to treatments. Childhood maltreatment information, therefore, appears mandatory in treatment planning and is a critical factor in therapeutic algorithms. Further research is needed to fully understand these pathways and develop new treatment modalities for individuals with mood disorders who have experienced childhood maltreatment and effective preventive interventions for individuals at risk of developing mood disorders. Keywords: biomarkers, childhood maltreatment, mood disorders, biosignatures, biotype Childhood maltreatment is an established risk factor for incident psychiatric disorders, including mood disorders (unipolar depressive disorder (UD) and bipolar disorder (BD)). 1 Childhood maltreatment is defined as exposure to actual or potential harm to a child including physical, sexual, or psychological abuse, neglect, or negligent treatment. 2 More than 10% of children are affected by maltreatment in high-income countries, 3,4 and the prevalence is even higher in low-income countries. 5 Among individuals with UD and BD, the figures are even higher, with approximately 25%, 6 and 40% 7 reporting severe childhood maltreatment, respectively. Further evidence supports that childhood maltreatment increases the risk of mood disorders substantially. 8,9 In addition, childhood maltreatment is associated with an earlier age at onset of mood disorder, a more severe illness course, impaired social functioning 10 including cognitive difficulties, 11 more perceived stress, lower quality of life, 12 sexual health problems, 13,14 and physical diseases. 15,16 The landmark study by Caspi et al 17,18 showed that the impact of severe life events seems mediated through genetic variation, variations that contributed to an increased vulnerability in maltreated children. Caspi et al found that individuals with two copies of the short allele of the serotonin transporter gene (5-HTTLPR) were more likely to develop depression in response to stressful life events than individuals with one or two copies of the long allele, and this vulnerability was most pronounced in individuals who had experienced severe life events. 19 The study suggested that genetic variations interact with environmental factors, such as childhood maltreatment, to increase the risk of developing mental health problems. Since this gene–environment interaction model has been studied extensively, gene-environmental actions initiated in childhood may lead to changes in biological substrates with a long-lasting impact at the individual level. 20,21 Increasing insight into proteomics, transcriptomics, genomics, and brain imaging has advanced the pathophysiological understanding of mood disorders. 22 However, there is a translational gap in clarifying to what extent such approaches can prove helpful in the clinic and help diagn -Abstract Truncated-
psychiatry,clinical neurology